Dirui Industrial Co.,Ltd. (300396.SZ)
CNY 13.36
(-0.07%)
CNY 13.36
(-0.07%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 | 275.58 Million CNY | 5.26% |
| 2022 | 261.82 Million CNY | 24.71% |
| 2021 | 209.94 Million CNY | -21.39% |
| 2020 | 267.07 Million CNY | 15.17% |
| 2019 | 231.89 Million CNY | 17.28% |
| 2018 | 197.72 Million CNY | 18.12% |
| 2017 | 167.39 Million CNY | 33.77% |
| 2016 | 125.13 Million CNY | 15.57% |
| 2015 | 108.27 Million CNY | 6.83% |
| 2014 | 101.35 Million CNY | 8.28% |
| 2013 | 93.6 Million CNY | 11.14% |
| 2012 | 84.22 Million CNY | 10.37% |
| 2011 | 76.31 Million CNY | 26.37% |
| 2010 | 60.38 Million CNY | 222.79% |
| 2009 | 18.7 Million CNY | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q2 | 43.44 Million CNY | -64.33% |
| 2024 Q3 | 27.33 Million CNY | -37.08% |
| 2024 Q1 | 121.8 Million CNY | 194.87% |
| 2023 Q1 | 77.71 Million CNY | 15.89% |
| 2023 Q3 | 72.46 Million CNY | -13.84% |
| 2023 Q2 | 84.1 Million CNY | 8.23% |
| 2023 FY | 275.58 Million CNY | 5.26% |
| 2023 Q4 | 41.3 Million CNY | -43.0% |
| 2022 Q3 | 62.04 Million CNY | -13.59% |
| 2022 Q2 | 71.8 Million CNY | 18.07% |
| 2022 FY | 261.82 Million CNY | 24.71% |
| 2022 Q4 | 67.05 Million CNY | 8.08% |
| 2022 Q1 | 60.81 Million CNY | 13.11% |
| 2021 Q2 | 51.48 Million CNY | -11.88% |
| 2021 Q1 | 58.42 Million CNY | 84.39% |
| 2021 FY | 209.94 Million CNY | -21.39% |
| 2021 Q4 | 53.76 Million CNY | 16.21% |
| 2021 Q3 | 46.26 Million CNY | -10.15% |
| 2020 Q2 | 70.17 Million CNY | 84.87% |
| 2020 Q4 | 31.68 Million CNY | -75.1% |
| 2020 Q3 | 127.25 Million CNY | 81.33% |
| 2020 FY | 267.07 Million CNY | 15.17% |
| 2020 Q1 | 37.95 Million CNY | -10.34% |
| 2019 Q4 | 42.33 Million CNY | -33.49% |
| 2019 FY | 231.89 Million CNY | 17.28% |
| 2019 Q3 | 63.65 Million CNY | -18.22% |
| 2019 Q2 | 77.83 Million CNY | 61.92% |
| 2019 Q1 | 48.07 Million CNY | 20.17% |
| 2018 Q2 | 66.99 Million CNY | 94.05% |
| 2018 Q1 | 34.52 Million CNY | 6.59% |
| 2018 FY | 197.72 Million CNY | 18.12% |
| 2018 Q4 | 40 Million CNY | -28.83% |
| 2018 Q3 | 56.2 Million CNY | -16.12% |
| 2017 FY | 167.39 Million CNY | 33.77% |
| 2017 Q1 | 27.41 Million CNY | -22.54% |
| 2017 Q2 | 63.72 Million CNY | 132.44% |
| 2017 Q3 | 43.86 Million CNY | -31.16% |
| 2017 Q4 | 32.39 Million CNY | -26.16% |
| 2016 Q3 | 27.29 Million CNY | -32.02% |
| 2016 FY | 125.13 Million CNY | 15.57% |
| 2016 Q1 | 22.29 Million CNY | -30.02% |
| 2016 Q2 | 40.15 Million CNY | 80.13% |
| 2016 Q4 | 35.39 Million CNY | 29.66% |
| 2015 Q3 | 28.39 Million CNY | -4.68% |
| 2015 Q4 | 31.85 Million CNY | 12.16% |
| 2015 Q2 | 29.79 Million CNY | 63.43% |
| 2015 Q1 | 18.23 Million CNY | -39.09% |
| 2015 FY | 108.27 Million CNY | 6.83% |
| 2014 Q2 | 28.01 Million CNY | 72.18% |
| 2014 Q1 | 16.27 Million CNY | -38.64% |
| 2014 Q4 | 29.93 Million CNY | 10.28% |
| 2014 Q3 | 27.14 Million CNY | -3.11% |
| 2014 FY | 101.35 Million CNY | 8.28% |
| 2013 Q3 | 29.23 Million CNY | 0.0% |
| 2013 FY | 93.6 Million CNY | 11.14% |
| 2013 Q4 | 26.51 Million CNY | -9.29% |
| 2012 FY | 84.22 Million CNY | 10.37% |
| 2011 FY | 76.31 Million CNY | 26.37% |
| 2010 FY | 60.38 Million CNY | 222.79% |
| 2009 FY | 18.7 Million CNY | 0.0% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| Dian Diagnostics Group Co.,Ltd. | 307.46 Million CNY | 10.366% |
| Hangzhou Tigermed Consulting Co., Ltd. | 2.02 Billion CNY | 86.39% |
| Beijing Strong Biotechnologies, Inc. | 523.74 Million CNY | 47.381% |
| Medicalsystem Biotechnology Co., Ltd. | 256.55 Million CNY | -7.421% |
| Maccura Biotechnology Co.Ltd | 312.61 Million CNY | 11.845% |
| Guangzhou Wondfo Biotech Co.,Ltd | 487.62 Million CNY | 43.483% |
| Guangdong Hybribio Biotech Co.,Ltd. | 140.47 Million CNY | -96.188% |
| BGI Genomics Co., Ltd. | 92.9 Million CNY | -196.651% |
| Amoy Diagnostics Co., Ltd. | 261.48 Million CNY | -5.394% |
| Shanghai Labway Clinical Laboratory Co., Ltd. | -141.59 Million CNY | 294.637% |